64.5 F
New York
Monday, October 2, 2023



Hemanext Announces Founder Martin Cannon’s Retirement, Appoints Andrew Dunham as CEO, and Raises Funding for Growth

Related Articles

Younok Dumortier Shin Honored as a Woman of the Month for July 2023 by P.O.W.E.R. – Professional Organization of Women of Excellence Recognized

West Windsor, NJ, September 29, 2023 --(PR.com)-- Younok Dumortier Shin of West Windsor, New Jersey, has been honored as a Woman of the Month for...

Meals on Wheels South Florida Receives Grant from Meals on Wheels America to Address Social Isolation and Loneliness in South Florida

Plantation, FL, September 28, 2023 --(PR.com)-- Meals on Wheels South Florida has announced today that it has received a $10,000 grant from Meals on Wheels...
Lexington, MA, September 18, 2023 –(PR.com)– Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, marks a significant turning point in its history as the company announces the retirement of its founder, Martin Cannon. Simultaneously, the Hemanext Board of Directors has appointed Andrew Dunham, the current Chief Technology Officer of Hemanext, to serve as Chief Executive Officer (CEO). These announcements come as the company proudly reveals the successful close of the B1 funding round totaling $25M, demonstrating strong investor support for its innovative technologies and commitment to enhancing patient care.

Martin Cannon, the visionary leader who founded Hemanext in 2008 with support from a National Institutes of Health (NIH) grant, leaves an enduring legacy. His exceptional foresight in recognizing the potential for enhancing red blood cell (RBC) quality, at a time when our understanding…

Read more…

Popular Articles